01 10Tagrisso
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 4,328
2019 Revenue in Millions : 3,189
Growth (%) : 36
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 5,015
2020 Revenue in Millions : 4,328
Growth (%) : 16
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 5,444
2021 Revenue in Millions : 5,015
Growth (%) : 9
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 5,799
2022 Revenue in Millions : 5,444
Growth (%) : 7
Main Therapeutic Indication : Oncology
Currency : USD
2024 Revenue in Millions : 6,580
2023 Revenue in Millions : 5,799
Growth (%) : 13
Main Therapeutic Indication : Oncology
Currency : USD
2015 Revenue in Millions : 0
2014 Revenue in Millions : 19
Growth (%) : New Launch
Main Therapeutic Indication : Oncology
Currency : USD
2017 Revenue in Millions : 955
2016 Revenue in Millions : 423
Growth (%) : 126
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 1,860
2017 Revenue in Millions : 955
Growth (%) : 95%
Main Therapeutic Indication : Oncology
Currency : USD
2016 Revenue in Millions : 423
2015 Revenue in Millions : 19
Growth (%) : 2,126
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 3,189
2018 Revenue in Millions : 1,860
Growth (%) : 71
